{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:47:31Z","timestamp":1785840451095,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T00:00:00Z","timestamp":1607126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013129","name":"Ministry of SMEs and Startups","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.12.013","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T04:28:27Z","timestamp":1608265707000},"page":"529-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2d"],"prefix":"10.1016","volume":"39","author":[{"given":"Kiju","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3919-1153","authenticated-orcid":false,"given":"Tae-Wook","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2020.12.013_b0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-animal-031412-103720","article-title":"Porcine circovirus type 2 (PCV2): pathogenesis and interaction with the immune system","volume":"1","author":"Meng","year":"2013","journal-title":"Annu Rev Anim Biosci"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.013_b0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1017\/S1466252310000162","article-title":"Epidemiology and horizontal transmission of porcine circovirus type 2 (PCV2)","volume":"11","author":"Patterson","year":"2010","journal-title":"Anim Health Res Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.013_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12917-019-2193-1","article-title":"Phylogenetic analysis of porcine circovirus type 2 (PCV2) between 2015 and 2018 in Henan Province, China","volume":"16","author":"Zheng","year":"2020","journal-title":"BMC Vet Res"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.013_b0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/104063870701900601","article-title":"Porcine circovirus type 2\u2013associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies","volume":"19","author":"Opriessnig","year":"2007","journal-title":"J Vet Diagn Invest"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.013_b0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virusres.2007.06.024","article-title":"Phylogenetic characterization of porcine circovirus type 2 in PMWS and PDNS Korean pigs between 1999 and 2006","volume":"129","author":"An","year":"2007","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.013_b0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.vaccine.2013.11.010","article-title":"A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 US variant mPCV2b strain","volume":"32","author":"Opriessnig","year":"2014","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2020.12.013_b0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.vetmic.2007.09.016","article-title":"Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case\u2013control study supports a shift in genotypes with time","volume":"128","author":"Dupont","year":"2008","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.013_b0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12985-015-0361-x","article-title":"Revisiting the taxonomical classification of Porcine Circovirus type 2 (PCV2): still a real challenge","volume":"12","author":"Franzo","year":"2015","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.013_b0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1743-422X-7-273","article-title":"Porcine circovirus type 2 (PCV2): genetic variation and newly emerging genotypes in China","volume":"7","author":"Guo","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2020.12.013_b0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.virusres.2016.02.010","article-title":"Diagnostic phylogenetics reveals a new porcine circovirus 2 cluster","volume":"217","author":"Davies","year":"2016","journal-title":"Virus Res"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.013_b0055","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/genomeA.01315-15","article-title":"Whole-genome sequences of novel porcine circovirus type 2 viruses detected in swine from Mexico and the United States","volume":"3","author":"Harmon","year":"2015","journal-title":"Genome Announc"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.013_b0060","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/tbed.13467","article-title":"Genetic diversity and prevalence of porcine circovirus type 3 (PCV3) and type 2 (PCV2) in the Midwest of the USA during 2016\u20132018","volume":"67","author":"Wang","year":"2019","journal-title":"Transbound Emerg Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2020.12.013_b0065","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4149\/av_2019_413","article-title":"Genetic variation and phylogenetic analysis of Porcine circovirus type 2 in China from 2016 to 2018","volume":"63","author":"Hou","year":"2019","journal-title":"Acta Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.12.013_b0070","article-title":"Transmission of porcine circovirus genotype type 2 (PCV2) in Russia and genotype association (PCV2d) with porcine dermatitis and nephropathy syndrome (PDNS)","volume":"315","author":"Raev","year":"2019","journal-title":"Earth Environ Sci"},{"key":"10.1016\/j.vaccine.2020.12.013_b0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.meegid.2019.03.013","article-title":"Phylogenetic analysis of porcine circovirus type 2 in Sardinia, Italy, shows genotype 2d circulation among domestic pigs and wild boars","volume":"71","author":"Dei Giudici","year":"2019","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2020.12.013_b0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.virusres.2016.11.015","article-title":"Genotypic diversity of porcine circovirus type 2 (PCV2) and genotype shift to PCV2d in Korean pig population","volume":"228","author":"Kwon","year":"2017","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.013_b0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/S1466252311000053","article-title":"Effect of porcine circovirus type 2 (PCV2) infection on reproduction: disease, vertical transmission, diagnostics and vaccination","volume":"12","author":"Madson","year":"2011","journal-title":"Anim Health Res Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.013_b0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jam.14473","article-title":"Oral vaccination with the porcine circovirus type 2 (PCV-2) capsid protein expressed by Lactococcus lactis induces a specific immune response against PCV-2 in mice","volume":"128","author":"Wang","year":"2020","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2020.12.013_b0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vetmic.2016.10.002","article-title":"Ten years of PCV2 vaccines and vaccination: is eradication a possibility?","volume":"206","author":"Afghah","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.12.013_b0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vetmic.2016.05.002","article-title":"National reduction in porcine circovirus type 2 prevalence following introduction of vaccination","volume":"189","author":"Dvorak","year":"2016","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.013_b0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2006.07.047","article-title":"Molecular evolution of porcine circovirus type 2 genomes: phylogeny and clonality","volume":"357","author":"Olvera","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.12.013_b0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.vetmic.2016.11.009","article-title":"PCV2d-2 is the predominant type of PCV2 DNA in pig samples collected in the US during 2014\u20132016","volume":"197","author":"Xiao","year":"2016","journal-title":"Vet Microbiol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2020.12.013_b0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.vetmic.2015.01.013","article-title":"Detection of a new cluster of porcine circovirus type 2b strains in domestic pigs in Germany","volume":"176","author":"Eddicks","year":"2015","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.013_b0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/genomeA.00163-14","article-title":"Identification of an emergent porcine circovirus-2 in vaccinated pigs from a Brazilian farm during a postweaning multisystemic wasting syndrome outbreak","volume":"2","author":"Salgado","year":"2014","journal-title":"Genome Announc"},{"issue":"11","key":"10.1016\/j.vaccine.2020.12.013_b0125","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1007\/s00705-014-2164-6","article-title":"Genetic and antigenic characterization of a newly emerging porcine circovirus type 2b mutant first isolated in cases of vaccine failure in Korea","volume":"159","author":"Seo","year":"2014","journal-title":"Arch Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2020.12.013_b0130","doi-asserted-by":"crossref","first-page":"12469","DOI":"10.1128\/JVI.02345-12","article-title":"Complete genome sequence of a novel porcine circovirus type 2b variant present in cases of vaccine failures in the United States","volume":"86","author":"Xiao","year":"2012","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2020.12.013_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041463","article-title":"A porcine circovirus type 2 (PCV2) mutant with 234 amino acids in capsid protein showed more virulence in vivo, compared with classical PCV2a\/b strain","volume":"7","author":"Guo","year":"2012","journal-title":"PLoS ONE"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2020.12.013_b0140","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1099\/vir.0.066423-0","article-title":"Mutant USA strain of porcine circovirus type 2 (mPCV2) exhibits similar virulence to the classical PCV2a and PCV2b strains in caesarean-derived, colostrum-deprived pigs","volume":"95","author":"Opriessnig","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.12.013_b0145","article-title":"T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines","volume":"110034","author":"Bandrick","year":"2020","journal-title":"Vet Immunol Immunopathol"},{"issue":"9","key":"10.1016\/j.vaccine.2020.12.013_b0150","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1007\/s00705-017-3414-1","article-title":"Genetic analysis of porcine circovirus type 2 in China","volume":"162","author":"Jiang","year":"2017","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.12.013_b0155","doi-asserted-by":"crossref","unstructured":"Wei R, Xie J, Theuns S, Nauwynck HJ. Changes on the viral capsid surface during the evolution of porcine circovirus type 2 (PCV2) from 2009 till 2018 may lead to a better receptor binding. Virus Evol 2019; 5(2): vez026.","DOI":"10.1093\/ve\/vez026"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.013_b0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1471-2180-11-188","article-title":"Identification of one critical amino acid that determines a conformational neutralizing epitope in the capsid protein of porcine circovirus type 2","volume":"11","author":"Huang","year":"2011","journal-title":"BMC Microbiol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2020.12.013_b0165","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.vetmic.2013.03.013","article-title":"Amino acid mutations in the capsid protein produce novel porcine circovirus type 2 neutralizing epitopes","volume":"165","author":"Liu","year":"2013","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.013_b0170","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.vaccine.2016.11.085","article-title":"A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naive pigs under experimental conditions","volume":"35","author":"Opriessnig","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.013_b0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.vaccine.2010.10.050","volume":"29","author":"Beach","year":"2010","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2020.12.013_b0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.vetmic.2012.01.024","article-title":"Vaccination with inactivated or live-attenuated chimeric PCV1\u20132 results in decreased viremia in challenge-exposed pigs and may reduce transmission of PCV2","volume":"158","author":"Hemann","year":"2012","journal-title":"Vet Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2020.12.013_b0185","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.05057-11","volume":"18","author":"Opriessnig","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.013_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-018-1098-0","article-title":"Characterization of a PCV2d-2 isolate by experimental infection of pigs","volume":"15","author":"Palya","year":"2018","journal-title":"Virol J"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.013_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007562","article-title":"Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope","volume":"15","author":"Mo","year":"2019","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.013_b0200","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1021\/bp034132i","article-title":"Rapid titer determination of baculovirus by quantitative real-time polymerase chain reaction","volume":"20","author":"Lo","year":"2004","journal-title":"Biotechnol Prog"},{"issue":"12","key":"10.1016\/j.vaccine.2020.12.013_b0205","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1007\/s00705-020-04831-z","article-title":"Deletion of a decoy epitope in porcine circovirus 2 (PCV2) capsid protein affects the protective immune response in mice","volume":"165","author":"Kim","year":"2020","journal-title":"Arch Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.013_b0210","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1631\/jzus.2007.B0162","article-title":"Detection of PCV2 DNA by SYBR green I-based quantitative PCR","volume":"8","author":"Yang","year":"2007","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.vaccine.2020.12.013_b0215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virol.2016.08.011","article-title":"A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs","volume":"498","author":"Matzinger","year":"2016","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.013_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12917-020-02304-8","article-title":"Molecular epidemiology and genetic variation analyses of porcine circovirus type 2 isolated from Yunnan Province in China from 2016\u20132019","volume":"16","author":"Lv","year":"2020","journal-title":"BMC Vet Res"},{"issue":"4","key":"10.1016\/j.vaccine.2020.12.013_b0225","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12088-019-00827-9","article-title":"Construction of a Lactobacillus plantarum strain expressing the capsid protein of porcine circovirus type 2d (PCV2d) as an oral vaccine","volume":"59","author":"Tseng","year":"2019","journal-title":"Indian J Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.013_b0230","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/CVI.00416-07","article-title":"Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2","volume":"15","author":"Opriessnig","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2020.12.013_b0235","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.vetmic.2013.06.011","article-title":"Multiple routes of porcine circovirus type 2 transmission to piglets in the presence of maternal immunity","volume":"166","author":"Dvorak","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.12.013_b0240","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.rvsc.2019.01.002","article-title":"A pilot comparative study of recombinant protein and whole-virus inactivated vaccines against porcine circovirus type 2 in conventionally reared pigs","volume":"123","author":"Choi","year":"2019","journal-title":"Res Vet Sci"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2020.12.013_b0245","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.vetmic.2007.06.004","article-title":"Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs","volume":"125","author":"Fort","year":"2007","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.013_b0250","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1297-9716-45-44","article-title":"Memory T cell proliferative responses and IFN-\u03b3 productivity sustain long-lasting efficacy of a Cap-based PCV2 vaccine upon PCV2 natural infection and associated disease","volume":"45","author":"Ferrari","year":"2014","journal-title":"Vet Res"},{"issue":"18","key":"10.1016\/j.vaccine.2020.12.013_b0255","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.3390\/ijms20184425","article-title":"Development of a combined genetic engineering vaccine for porcine circovirus type 2 and Mycoplasma hyopneumoniae by a baculovirus expression system","volume":"20","author":"Tao","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2020.12.013_b0260","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.virusres.2007.10.013","article-title":"Evidence for recombination between PCV2a and PCV2b in the field","volume":"132","author":"Hesse","year":"2008","journal-title":"Virus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:52:03Z","timestamp":1759402323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20315802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20315802"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2d","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}